Beyond the PwC scandal, there’s a growing case for a royal commission into Australia’s ruthless corporate greed 
A Nasa spacecraft is on course to deliver material from an asteroid to Earth – here's what we could learn 
Jordan Brand Resale Value Dips; Competitors See Growth, Investors Wary 
Krispy Kreme, Tim Hortons, Wendy’s, Dunkin’ Reveals Free Coffee, Big Discounts on National Coffee Day 
Mitsubishi Motors Plans China Exit Amid EV Market Shift 
Honda Announces Release of Honda Prologue, its First Electric SUV in North America 
Mister Donut to Launch Instant Ramen in Japan, Celebrating 30 Years of Dim Sum 
Intel Ramps Up 'Landmark' Production Using EUV Lithography Machines in Ireland 
Blockchain Unicorn Fireblocks Acquires Australian Tokenization Startup BlockFold 
In a Stone Age cemetery, DNA reveals a treasured 'founding father' and a legacy of prosperity for his sons 
Researchers dig deep underground in hopes of finally observing dark matter 
Eli Lilly's Alzheimer's Drug Donanemab Shows Potential to Delay Disease Progression: Seeks FDA Approval 
- News
- Economy
- Central Banks
- Investing
- Research
- Roundups
- Digital Currency
- Insights
- Technical Analysis
- Technology
- Business
- Law
- Health
- Nature
- Fintech
- Science
- Topic
- Opinions
- ©PUBLISH holdings LLC . All Rights Reserved.
Olympus to sell microscope unit to Bain for $3 billion, focus on medical technology
Olympus said the transfer to Bain would be in its best interest to allow the business to grow with more agile and flexible decision-making based on market needs.
Olympus had agreed to sell its microscope unit to private equity firm Bain Capital for $3.1 billion as it speeds up the overhaul of its business portfolio to focus solely on medical technology
The microscope unit, which also manufactures industrial endoscopes and x-ray analyzers, will be transferred to Bain on January 4, subject to antitrust regulatory approvals in Japan and elsewhere.
Olympus stated that the transfer to Bain would benefit the company by allowing it to grow through more agile and flexible decision-making based on market needs.
Bain edged global private equity firms such as Carlyle Group and KKR & Co. for the right to acquire the microscope unit.
Olympus said the transfer to Bain would be in its best interest to allow the business to grow with more agile and flexible decision-making based on market needs.
Bain won over global private equity firms such as Carlyle Group and KKR & Co.
Bain owns flash memory chip maker Kioxia Holdings and is proceeding to a second bidding round for Toshiba.
Editor's Picks
- Market Data
